Respiratory Virus Vaccines Market:Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Aug 2020| TMR2090A| Transparency

Report Highlights

Respiratory Virus Vaccines Market - Scope of the Report

TMR’s report on the global respiratory virus vaccines market studies the past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global respiratory virus vaccines market for period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global respiratory virus vaccines market for the same period.

The report has been prepared after extensive research. Primary research involves bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global respiratory virus vaccines market.

Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global respiratory virus vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global respiratory virus vaccines market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global respiratory virus vaccines market. The next section of the report highlights the USPs, which include pipeline analysis, disease prevalence & incidence rate globally with key countries, key industry events (mergers, acquisitions, collaborations, approvals, etc.) and COVID-19 pandemic impact on industry (value chain and short-/mid-/ long-term impact).

The report delves into the competitive landscape of the global respiratory virus vaccines market. Key players operating in the global respiratory virus vaccines market have been identified and each one of them has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global respiratory virus vaccines market profiled in this report.

Key Questions Answered in Respiratory Virus Vaccines Market Report

  • What are the major drivers, restraints, and opportunities in the global respiratory virus vaccines market?
  • What is the revenue share projection of key segments of the global respiratory virus vaccines market during the forecast period?
  • Which segment is likely to lead the global respiratory virus vaccines market in terms of revenue between 2020 and 2030?
  • How mergers & acquisitions among players are widening the scope of the global respiratory virus vaccines market?
  • What is the market position of different companies operating in the global respiratory virus vaccines market?

Respiratory Virus Vaccines Market - Research Objectives and Research Approach

The comprehensive report on the global respiratory virus vaccines market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the globaal respiratory virus vaccines market. It is followed by market introduction, market dynamics, and an overview of the global respiratory virus vaccines market, which includes TMR’s analysis of market drivers, restraints, and trends pertaining to the global respiratory virus vaccines market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global respiratory virus vaccines market. The next section of the global respiratory virus vaccines report highlights the USPs, which include pipeline analysis, disease prevalence & incidence rate globally with key countries, key industry events (mergers, acquisitions, collaborations, approvals, etc.) and COVID-19 pandemic impact on industry (value chain and short-/mid-/long-term impact).

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report segments the global respiratory virus vaccines market in terms of type, route of administration, indication, age group, end user, and region. Key segments under each criterion have been studied at length and the market share for each segment by the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global respiratory virus vaccines market.

  • Table 1 : Pipeline Analysis (1/4)
  • Table 2 : Pipeline Analysis (2/4)
  • Table 3 : Pipeline Analysis (3/4)
  • Table 4 : Pipeline Analysis (4/4)
  • Table 5 : Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (1/3)
  • Table 6 : Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (2/3)
  • Table 7 : Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (3/3)
  • Table 8 : Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030
  • Table 9 : Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
  • Table 10 : Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030
  • Table 11 : Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030
  • Table 12 : Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030
  • Table 13 : Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Region, 2018–2030
  • Table 14 : North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country, 2018–2030
  • Table 15 : North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030
  • Table 16 : North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
  • Table 17 : North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030
  • Table 18 : North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030
  • Table 19 : North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030
  • Table 20 : Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
  • Table 21 : Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030
  • Table 22 : Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
  • Table 23 : Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030
  • Table 24 : Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030
  • Table 25 : Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030
  • Table 26 : Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
  • Table 27 : Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030
  • Table 28 : Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
  • Table 29 : Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030
  • Table 30 : Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030
  • Table 31 : Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030
  • Table 32 : Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
  • Table 33 : Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030
  • Table 34 : Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
  • Table 35 : Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030
  • Table 36 : Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030
  • Table 37 : Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030
  • Table 38 : Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
  • Table 39 : Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030
  • Table 40 : Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
  • Table 41 : Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030
  • Table 42 : Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030
  • Table 43 : Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030
  • Figure 1 : Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 2 : Global Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030
  • Figure 3 : Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 4 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Inactivated/Killed Vaccines, 2018-2030
  • Figure 5 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Live-attenuated Vaccines, 2018-2030
  • Figure 6 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant vaccines, 2018-2030
  • Figure 7 : Global Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 8 : Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 9 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Intramuscular, 2018-2030
  • Figure 10 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Intranasal, 2018-2030
  • Figure 11 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Subcutaneous, 2018-2030
  • Figure 12 : Global Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 13 : Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 14 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Influenza, 2018-2030
  • Figure 15 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Measles, Mumps & Rubella, 2018-2030
  • Figure 16 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Coronavirus Disease (COVID-19), 2018-2030
  • Figure 17 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 18 : Global Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030
  • Figure 19 : Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030
  • Figure 20 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Pediatric, 2018-2030
  • Figure 21 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Adult, 2018-2030
  • Figure 22 : Global Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 23 : Global Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 24 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Physician Offices, 2018-2030
  • Figure 25 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2018-2030
  • Figure 26 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Clinics, 2018-2030
  • Figure 27 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Pharmacy/Store, 2018-2030
  • Figure 28 : Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 29 : Global Respiratory Virus Vaccines Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 30 : Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 31 : North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 32 : North America Respiratory Virus Vaccines Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 33 : North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 34 : North America Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030
  • Figure 35 : North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 36 : North America Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 37 : North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 38 : North America Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 39 : North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 40 : North America Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030
  • Figure 41 : North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030
  • Figure 42 : North America Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 43 : North America Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 44 : Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 45 : Europe Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 46 : Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 47 : Europe Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030
  • Figure 48 : Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 49 : Europe Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 50 : Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 51 : Europe Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 52 : Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 53 : Europe Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030
  • Figure 54 : Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030
  • Figure 55 : Europe Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 56 : Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 57 : Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 58 : Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 59 : Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 60 : Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030
  • Figure 61 : Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 62 : Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 63 : Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 64 : Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 65 : Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 66 : Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030
  • Figure 67 : Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030
  • Figure 68 : Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 69 : Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 70 : Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 71 : Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 72 : Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 73 : Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030
  • Figure 74 : Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 75 : Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 76 : Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 77 : Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 78 : Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 79 : Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030
  • Figure 80 : Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030
  • Figure 81 : Latin America Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 82 : Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 83 : Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 84 : Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 85 : Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 86 : Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030
  • Figure 87 : Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 88 : Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 89 : Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 90 : Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 91 : Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 92 : Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030
  • Figure 93 : Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020-2030
  • Figure 94 : Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 95 : Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020-2030

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report